| Literature DB >> 18813051 |
Robert D Sanders1, Jörg Weimann, Mervyn Maze.
Abstract
Nitrous oxide is the longest serving member of the anesthesiologist's pharmacologic armamentarium but remains a source of controversy because of fears over its adverse effects. Recently, the Evaluation of Nitrous oxide In a Gas Mixture for Anaesthesia (ENIGMA) trial reported that nitrous oxide use increases postoperative complications; further preclinical reports have suggested that nitrous oxide may contribute to neurocognitive dysfunction in the young and elderly. Therefore, nitrous oxide's longevity in anesthetic practice is under threat. In this article, the authors discuss the evidence for the putative toxicity of nitrous oxide, from either patient or occupational exposure, within the context of the mechanism of nitrous oxide's action. Although it would seem prudent to avoid nitrous oxide in certain vulnerable populations, current evidence in support of a more widespread prescription from clinical practice is unconvincing.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18813051 DOI: 10.1097/ALN.0b013e3181870a17
Source DB: PubMed Journal: Anesthesiology ISSN: 0003-3022 Impact factor: 7.892